Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler
Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol, 40 mcg and 80 mcg. The product is a generic equivalent of QVAR Inhalation Aerosol, 40 mcg and 80 mcg, marketed by Teva Branded Pharmaceutical Products R&D LLC. It is Aurobindo’s…
Read More “Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler” »